Basit öğe kaydını göster

dc.contributor.authorUmar, Rashida Muhammad
dc.contributor.authorApikoğlu-Rabuş, Şule
dc.contributor.authorYumuk, Perran Fulden
dc.date.accessioned2020-07-13T08:41:19Z
dc.date.available2020-07-13T08:41:19Z
dc.date.issued2020en_US
dc.identifier.citationUmar, R. M., Apikoğlu-Rabuş, Ş. ve Yumuk, P. F. (2020). Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients. International Journal of Clinical Pharmacy, 42(2), 652-661. https://dx.doi.org/10.1007/s11096-020-00992-8en_US
dc.identifier.issn2210-7703
dc.identifier.issn2210-7711
dc.identifier.urihttps://dx.doi.org/10.1007/s11096-020-00992-8
dc.identifier.urihttps://hdl.handle.net/20.500.12511/5464
dc.description.abstractBackground The use of highly toxic drugs in cancer treatment and supportive care medications exposes patients to an increased number of drug-related problems (DRPs). Clinical pharmacists contribute to the optimal use of medications by intervening in identified drug-related problems. Objective To evaluate the relevance of a comprehensive medication management service in oncology patients. Setting Marmara University Teaching and Research Hospital Medical Oncology Ward, Istanbul, Turkey. Methods This prospective study was carried out between December 2015 and April 2016 with adult patients with confirmed malignancy. Comprehensive medication management was performed by the clinical pharmacist throughout the patient's hospital stay. The medication-related data as well as data regarding demographic and general health status of the patients were reviewed for the presence of drug-related problems. The identified problems, interventions and acceptance rate by physicians were recorded with the help of the Pharmaceutical Care Network Europe V6.0 (PCNE) classification. Main outcome measures Number and causes of drug-related problems, nature and acceptance rate of clinical pharmacist interventions and rate of problems solved. Results The study included 137 patients. The mean (SD) age of the patients was 58 (14.6) years. A total of 481 drug-related problems were recorded. The most frequent drug-related problems were 'adverse drug events [including drug interactions]' (n = 376), 'untreated indications' (n = 59) and 'unnecessary drug treatment' (n = 25). Inappropriate combination of drugs was the cause of 73.2% of the total problems. Interventions were made to stop administration of a suitable drug if the combination with another drug was contraindicated while prescribers were mostly informed about major drug interactions. The prescribers approved 93% of the total intervention proposals. The majority (90.9%) of the identified problems were totally solved. Conclusion Integration of clinical pharmacy services through a comprehensive medication management program in oncology will help to reduce the number of drug-related problems.en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectClinical Pharmacisten_US
dc.subjectDrug-Related Problemsen_US
dc.subjectMedication Managementen_US
dc.subjectOncologyen_US
dc.subjectTurkeyen_US
dc.titleSignificance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patientsen_US
dc.typearticleen_US
dc.relation.ispartofInternational Journal of Clinical Pharmacyen_US
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalıen_US
dc.authorid0000-0001-8902-7274en_US
dc.identifier.volume42en_US
dc.identifier.issue2en_US
dc.identifier.startpage652en_US
dc.identifier.endpage661en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1007/s11096-020-00992-8en_US
dc.identifier.wosqualityQ4en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster